Specifically, DPPIV is an important regulator of diabetes, obesity, hypertension, inflammation, and glucose metabolism—all of which are linked to the chronic cerebrovascular dysfunctions that follow COVID-19. The gene discussed is DPP4; the disease is obesity due to melanocortin 4 receptor deficiency.